Gene · 6595
Papers3,459
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
621 to 640 of 3,459
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Reprogramming Carbohydrate Metabolism in Cancer and Its Role in Regulating the Tumor Microenvironment. | Subcell Biochem | 2022 | 36301490 | PubTator, text mining | PubMed |
| How Our Microbiome Influences the Pathogenesis of Alopecia Areata. | Genes (Basel) | 2022 | 36292745 | PubTator, text mining | PubMed |
| Wiedemann-Steiner Syndrome: Case Report and Review of Literature. | Children (Basel) | 2022 | 36291481 | PubTator, text mining | PubMed |
| Identification of bromodomain-containing proteins prognostic value and expression significance based on a genomic landscape analysis of ovarian serous cystadenocarcinoma. | Front Oncol | 2022 | 36276071 | PubTator, text mining | PubMed |
| Biophysical insights into glucose-dependent transcriptional regulation by PDX1. | J Biol Chem | 2022 | 36272648 | PubTator, text mining | PubMed |
| Identification of proteomic landscape of drug-binding proteins in live cells by proximity-dependent target ID. | Cell Chem Biol | 2022 | 36272407 | PubTator, text mining | PubMed |
| PDCD5 inhibits progression of renal cell carcinoma by promoting T cell immunity: with the involvement of the HDAC3/microRNA-195-5p/SGK1. | Clin Epigenetics | 2022 | 36266728 | PubTator, text mining | PubMed |
| Circadian lncRNA ADIRF-AS1 binds PBAF and regulates renal clear cell tumorigenesis. | Cell Rep | 2022 | 36261012 | PubTator, text mining | PubMed |
| CRISPR/Cas9: A revolutionary genome editing tool for human cancers treatment. | Technol Cancer Res Treat | 2022 | 36254536 | PubTator, text mining | PubMed |
| Small cell carcinoma of the ovary hypercalcemic type (SCCOHT): A review and novel case with dual germline SMARCA4 and BRCA2 mutations. | Gynecol Oncol Rep | 2022 | 36249907 | PubTator, text mining | PubMed |
| Selective vulnerability of ARID1A deficient colon cancer cells to combined radiation and ATR-inhibitor therapy. | Front Oncol | 2022 | 36249060 | PubTator, text mining | PubMed |
| Diverse selection pressures shaping the genetic architecture of behçet disease susceptibility. | Front Genet | 2022 | 36246630 | PubTator, text mining | PubMed |
| Discovery of E3 Ligase Ligands for Target Protein Degradation. | Molecules | 2022 | 36235052 | PubTator, text mining | PubMed |
| Survival Benefit of Adjuvant Chemotherapy in Pulmonary Carcinoid Tumors. | Cancers (Basel) | 2022 | 36230651 | PubTator, text mining | PubMed |
| Selective and Cell-Active PBRM1 Bromodomain Inhibitors Discovered through NMR Fragment Screening. | J Med Chem | 2022 | 36227159 | PubTator, text mining | PubMed |
| Current understanding of epigenetics role in melanoma treatment and resistance. | Cancer Cell Int | 2022 | 36224606 | PubTator, text mining | PubMed |
| Diagnostic Potential of the Serum lncRNAs HOTAIR, BRM and ICR for Hepatocellular Carcinoma. | Front Biosci (Landmark Ed) | 2022 | 36224021 | PubTator, text mining | PubMed |
| A selective and orally bioavailable VHL-recruiting PROTAC achieves SMARCA2 degradation in vivo. | Nat Commun | 2022 | 36216795 | PubTator, text mining | PubMed |
| Antisense non-coding transcription represses the PHO5 model gene at the level of promoter chromatin structure. | PLoS Genet | 2022 | 36215302 | PubTator, text mining | PubMed |
| Predicting the structural basis of targeted protein degradation by integrating molecular dynamics simulations with structural mass spectrometry. | Nat Commun | 2022 | 36202813 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6595/papers?page=32